You searched for "drops"

1267 results found

Midland Eye performs its first Presserflo Microshunt to treat Glaucoma

Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.

Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital

The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...

Advances in cataract surgery

This article covers recent clinical findings in mydriasis and anaesthesia for cataract surgery, shared by Sathish Srinivasan and Keith Davey at a surgical meeting in Manchester. Towards dropless cataract surgery Day case cataract surgery is the standard of care in...

BMLA 2023 Annual Conference & Educational Courses

Navroz Singh (far right) with Nirmal and Vasant Oswal (second and third left) and the other recipients of the Vasant and Nirmal Oswal Trainee Scholarship. Navroz Singh, core surgical trainee at Kings College NHS Trust. This year’s British Medical Laser...

Happy hour

Welcome Eye News Aug/Sep 2023, your bi-monthly tonic for a much-needed happy hour. In the current climate of challenge across all fronts, there’s no better time to reach out for the professional equivalent of a cheery cup in the company...

PUK after corneal crosslinking

This retrospective study aimed to report the incidence, characteristics, clinical presentations, risk factors, and the available treatment modalities of sterile peripheral ulcerative keratitis (PUK) post-corneal collagen crosslinking (CXL). In total 771 eyes of 474 patients operated for keratoconus or ectasia...

Prostaglandin associated periorbitopathy

Prostaglandins are known to cause periorbital adverse effects. The aim of this retrospective case series was to compare the frequency of prostaglandin associated periorbitopathy (PAP) between bimatoprost, latanoprost and travoprost users. Five PAP findings were evaluated: upper lid ptosis, deepening...

Chronic drop use and trabeculectomy on tear osmolarity

Ocular surface disease (OSD) is common in patients chronically treated for glaucoma. This may be related to the drug itself but often to the preservatives in the medication. Much work has been done on the most common preservative, benzalkonium chloride...

Nanoparticle administration of latanoprost

Glaucoma is a progressive optic neuropathy characterised by increased ocular pressure and loss of retinal ganglion cells. Conventional drug therapy with eye drops to reduce intraocular pressure (IOP) has variable bioavailability and can lead to ocular surface disease. In this...

Impact of medical vs. surgical treatment on quality of life in glaucoma patients

The author recruited 225 patients across two sites and divided them into three groups. Group 1 medical treatment only, Group 2 surgical treatment only, Group 3 mixed medical and surgical (patients still on drops after surgery). They then used a...

Intraocular pressure changes following TOHM washout

This retrospective study between 2008 and 2019 of 110 eyes with primary open angle glaucoma (POAG), 33 eyes with ocular hypertension (OHT) and 43 eyes with uveitic glaucoma (UG) evaluated the changes in intraocular pressure (IOP) following topical ocular hypotensive...

100% Optical and Optrafair organisers join forces

From now on there will be one major annual exhibition, 100% Optical at London’s ExCeL exhibition centre, which has full industry support from the FMO and other major optical bodies.